Ovarian hyperstimulation syndrome (OHSS) occurs mostly as an iatrogenic complication of assisted reproductive technology. Gonadotroph pituitary adenomas are rarely associated with OHSS. To the authors' knowledge, to date only 30 cases of spontaneous ovarian stimulation associated with gonadotroph adenomas have been reported in women and only 2 in children. The most common symptoms in such cases included menstrual disturbances, abdominal or pelvic pain, abdominal distension and increased girth. Galactorrhea, nausea and vomiting were also reported. Neurological symptoms occurred when the size of the pituitary tumor reached at least 20 mm. Transvaginal ultrasound examination usually demonstrated enlarged multicystic ovaries. MRIs of the pituitary revealed macroadenomas up to 61 mm in maximum diameter. The hormonal profiles of the reported cases showed normal or elevated FSH levels, suppressed LH levels, elevated estradiol levels and supranormal concentrations of prolactin. Transsphenoidal surgery is the therapy of choice, however other treatment modalities can be utilized in selected cases (Adv Clin Exp Med 2015, 24, 4, 695-703).
Ovarian hyperstimulation syndrome (OHSS) occurs mostly as an iatrogenic complication of assisted reproductive technology [1] . Classification of OHSS is based on clinical features and laboratory findings. Symptoms vary from abdominal pain and bloating, nausea, vomiting and ovarian enlargement to possibly life-threatening conditions including renal failure, hypovolemic shock, adult respiratory distress syndrome, thromboembolism and pericardial effusion. As Mathur et al. pointed out, the cause of severe forms of OHSS is "an increase in vascular permeability resulting in a fluid shift from intravascular to third-space compartments" [2] . Vascular endothelial growth factor (VEGF) produced in stimulated ovaries under the influence of human chorionic gonadotropin (hCG) is thought to play a crucial role in the pathophysiology of OHSS [3] . Elevated VEGF blood levels correlate with the development of OHSS and its severity [4] . Spontaneous OHSS is rarely reported and usually associated with primary hypothyroidism, bilateral granulosa cell tumors and spontaneous pregnancy in women with polycystic ovary syndrome [5] . Follicle-stimulating hormone receptor gene polymorphisms might be responsible for modulating receptor sensitivity and susceptibility to OHSS [6] .
To the authors' knowledge, only 32 cases of spontaneous ovarian stimulation induced by gonadotroph pituitary adenomas have been published (Table 1) . Gonadotropinomas comprise 80-90% of the clinically nonfunctioning pituitary adenomas and account for 40-50% of all pituitary macroadenomas [7] . In vitro studies suggest that they are equally common in middle-aged men and women; however, they are difficult to diagnose in post-menopausal women because of physiological increases in the serum concentration of gonadotropins [8] . Gonadotroph adenomas rarely produce a recognizable clinical syndrome. They are usually revealed by symptoms due to mass effects such as visual impairment, headaches and hormonal deficiencies [9] .
Clinical Presentation
To date, 30 cases of spontaneous ovarian stimulation associated with gonadotroph adenomas have been reported in women and only two in children. Clinical manifestations vary from precocious puberty to OHSS. The patients' age ranged from 10 to 43 years. Menstrual disorders were the main reason medical attention was sought. The most common disturbances included amenorrhea, oligomenorrhea and irregular menses. Metrorrhagia and menometrorrhagia have been mentioned in only three papers. Other complaints were abdominal or pelvic pain, abdominal distension and increased girth, and difficulties in conceiving. Less common findings were galactorrhea, nausea and vomiting. Neurological symptoms occurred when the size of the pituitary tumor reached 20 mm or more in diameter. Deficits in visual field examinations were disclosed in 7 patients. Bitemporal hemianopsia was the most common defect. Additionally, two patients experienced loss of visual acuity. Growth hormone deficiency was noted at an initial examination in one case. Pituitary imaging almost always depicted a macroadenoma. The size of the tumors in the reviewed cases ranged from 7 mm to 61 mm in maximum diameter (Table 1) .
Immunohistochemical techniques are required to confirm a diagnosis of gonadotroph pituitary adenoma [10] . Immunostaining of the resected tumor tissue can be positive even when there is no measurable hormone secretion [11, 12] . Ultrasound examination usually revealed multicystic enlarged ovaries, similar to the ovaries seen in OHSS resulting from exogenous gonadotropin administration [13, 14] . Sicilia et al. reported a case of a 29-year-old woman who presented with acute abdomen caused by ovarian torsion. The ovaries were multicystic and measured >15 cm [15] . In the reviewed cases, the largest depicted ovary measured 20 cm in diameter (Table 1 ). In most of the reported cases ascites was not detected. The literature suggests that ascites is attributable to iatrogenic OHSS, which makes it a distinguishing feature of this entity [13, 16, 17] . Nonetheless, a small volume of ascites has been found in a few cases of women with developed ovarian hyperstimulation [14, 18] . Kanaya et al. described the case of a 32-year-old woman who became pregnant naturally and developed severe OHSS in the 5 th week of gestation. After the termination of the pregnancy the ascites resolved but multicystic ovarian enlargement emerged again. The authors stated that FSH stimulation itself is not sufficient to provoke ascites, and that LH or hCG stimulation is required in addition [19] . Menstrual disturbances, infertility and multiple ovarian cysts may resemble polycystic ovary syndrome (PCOS). However, ovarian follicles in women with PCOS are rarely larger than 10mm.
Another important feature in differential diagnosis is the fact that the FSH/LH ratio is usually decreased in PCOS and elevated in subjects with pituitary tumors [20] . The hormonal profiles in the reported cases of OHSS induced by gonadotroph pituitary adenomas showed normal or increased FSH levels (normal FSH in 17 out of 31 cases; elevated FSH in 14 out of 31 cases), suppressed LH levels (27 out of 32 cases), increased estradiol levels (29 out of 32 cases) and supranormal concentrations of prolactin (24 out of 27 cases). In a few cases α-subunit concentrations were estimated. Elevated α-subunit levels may indicate the presence of pituitary adenoma [8, 9] . FSH secreted by the tumor cells causes the formation of the multiple ovarian cysts and may considerably increase the production of estradiol [21, 22] . In some reports high estradiol levels contributed to the development of endometrial hyperplasia [17, 21, 23] . As a result of the negative feedback mechanism, FSH may remain within the normal range. However, in almost half of the reviewed cases FSH levels were elevated, which supports the theory of impaired negative feedback mechanism [24] . Normal FSH concentrations are capable of inducing OHSS, probably because of enhanced FSH bioactivity [25, 26] . Kajitani et al. found that the serum FSH bioactivity/immunoactivity ratio in a patient with gonadotroph adenoma was "mostly equal" to the ratios found in two healthy women. Therefore, a mechanism other than enhanced bioactivity may be responsible for the development of OHSS [27] . These findings were consistent with Kanaya's study [19] . The two-cell, two--gonadotropin theory states that FSH and LH are both required to stimulate the ovaries to secrete estrogens. LH stimulates the theca cells to produce androgens, which are then transported to the granulosa cells and aromatized to estrogens under the influence of FSH [17, 25] . However, in most of the reported cases LH levels were decreased. It is presumed that such low levels are sufficient to produce estradiol [19] . LH levels below the reference range are explained by estrogen-induced negative feedback mechanism or by the compression of normal pituitary tissue [21, 25] . Other suggested mechanisms responsible for suppressed LH levels involve inhibition of pituitary LHRH receptors or inhibition of LHRH secretion from the hypothalamus due to an abnormal form of FSH [22] . In postmenopausal women gonadotropinomas are not recognizable unless suppressed LH levels are detected [28] . In women over the age of 45 years ovaries are not sensitive to FSH stimulation. Thus, the clinical picture does not involve OHSS [21] . In patients with gonadotroph adenomas a paradoxical responses of LH, FSH or their subunits to thyrotropin releasing hormone (TRH) stimulation tests is found even if basal levels of these hormones are normal [8, 9, 29, 30] . This test can be utilized in the diagnosis [31] . It has to be emphasized that the TRH test is not always positive [25, 32] . The gonadotropin-releasing hormone (GnRH) test is also used in the diagnosis [12, 13, 33] .
Hyperprolactinemia, which is noted in most cases of gonadotroph pituitary adenoma, may be caused by pituitary stalk compression or high estradiol concentrations [12, 21, 26] . Elevated prolactin levels are sometimes the first discovered hormonal disorder. An MRI performed because of increased prolactin levels can reveal the presence of a pituitary adenoma [13, 25] .
Treatment
Transsphenoidal tumor resection is the approach of choice. Regression of enlarged multicystic ovaries, restoration of regular menstrual cycles and normalization in hormone levels can be observed after this surgery [5, 13] . The paradoxical responses of FSH, LH and their subunits to TRH stimulation test are no longer present postoperatively [12, 34] . Spontaneous pregnancies have also been observed in a few reports [18, 35, 36] . Castelbaum et al. reported a case of a woman who became pregnant ten months after the excision of a gonadotroph adenoma [20] . Patients who have undergone operations should be closely monitored due to the risk of pituitary insufficiency and diabetes insipidus [17, 21, 37] . Recurrent and remnant tumors were common, occurring in 11 out of 29 cases; 4 patients therefore underwent reoperation. Radiotherapy and radiosurgery are used in the management of the residual or recurrent tumors [7, 17, 21, 23, 26, 37, 38] .
In general, medical therapy is thought to be ineffective [5, 13] . Gonadotropin-releasing hormone agonists are not recommended. Administration of leuprolide resulted in elevation of estradiol and FSH levels and further ovarian cyst enlargement after one month of treatment [20] . Exacerbation of ovarian hyperstimulation during GnRH agonist therapy has also been noticed by other authors [19] , which may suggest the presence of a pituitary gonadotroph adenoma [20] . In one case, GnRH analog administration resulted in a slight increase in tumor size [39] . Macchia et al. reported that long-acting leuprolide injection neither reduced serum estradiol and FSH levels nor prevented a rapid relapse of OHSS [13] . Furthermore, the first dose of leuprolide can induce pituitary apoplexy in a patient with asymptomatic gonadotroph adenoma [40] .
Data on treatment with gonadotropin-releasing hormone antagonists is limited. In one report, a 30-day treatment using a GnRH antagonist and cabergoline resulted in a decrease in serum estradiol levels and improvement in the patient's clinical condition, with considerable reduction in ovarian volume. After GnRH antagonist cessation, estradiol levels increased and ultrasound disclosed further ovarian enlargement [10] . However, in another study, 4-week GnRH antagonist therapy did not normalize FSH, LH and α-subunit concentrations [21] .
Dopamine agonists, such as bromocriptine and cabergoline, can effectively reduce prolactin levels [10, 17, 25, 29, 39] . Additionally, cabergoline therapy can decrease estradiol and FSH levels [29] . Ovarian size reduction and suppression of estradiol levels were observed after the addition of cabergoline to medroxyprogesterone acetate treatment [39] . In the case of a 40-year old woman, bromocriptine administration restored regular menstrual cycles and resolved galactorrhea [39] . Somatostatin analogs might be also taken into consideration in selected cases [23] .
Conclusions
Gonadotroph pituitary can be a cause of ovarian hyperstimulation. The clinical presentation commonly includes menstrual disturbances and multicystic ovarian enlargement. In such cases evaluation of concentrations of estradiol and gonadotropins is recommended. The typical endocrine profile reveals supranormal estradiol levels, normal or elevated FSH and suppressed LH values, which should be an indication for pituitary imaging. Transsphenoidal surgery is the treatment of choice. A detailed examination facilitates the proper diagnosis, thus unnecessary ovarian surgery can be avoided.
